Powered by OmniSphere, Titan XT is built to support evolving healthcare needs while delivering greater pharmacy control and nursing confidence for a growing enterprise FORT WORTH, Texas--(BUSINESS ...
Bank of America upgraded Omnicell (OMCL) to Buy from Neutral and hiked its price target to $70 from $53 per share, citing a ...
Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing System FORT WORTH, Texas--(BUSINESS WIRE)-- Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”) ...
FORT WORTH, Texas - Omnicell, Inc. (NASDAQ:OMCL) announced Monday the launch of Titan XT, an enterprise version of its automated dispensing systems designed to enhance medication management across ...
Marietta, Ga.-based WellStar Health System selected Omnicell’s automated medication management solutions and analytics tools for use in its facilities. Omnicell’s solutions and tools will be ...
Omnicell shares have upside as a new product cycle drives revenue revisions, Bank of America said, upgrading the hospital automation company to Buy from Neutral. The bank said the launch of Omnicell’s ...
CEO Randall Lipps highlighted strong Q1 2025 performance driven by demand for Omnicell's medication management platform. Key focus areas included market share growth in inpatient and outpatient ...
Medication, supply management solutions and analytics software provider Omnicell announced today that it has partnered with Codonics, a company for patient safety and image documentation. The ...
Investing.com -- KeyBanc Capital Markets upgraded Omnicell to Overweight, saying the company is positioned for stronger revenue and earnings growth over the coming years as it enters in a potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results